At 2.8% of CAGR Sarcoma Biopsy Market Share Touch US$ 247.47 Million by the End of 2027 | Latest CMI
) , by End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 192.55 million in 2019, and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Global sarcoma biopsy market is expected to witness to significant growth during the forecast period, owing to increasing te...
Source: pharmiweb.com